TrialInternational journal of clinical oncology2017
Final report of KSCC0803: feasibility study of capecitabine as adjuvant chemotherapy for stage III colon cancer in Japan.
Kazuhito Minami et al.PubMed ↗Publisher ↗
No numbers read from the abstract.